These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 26400814)

  • 1. Role of Circulating Cell-Free DNA in Cancers.
    Aarthy R; Mani S; Velusami S; Sundarsingh S; Rajkumar T
    Mol Diagn Ther; 2015 Dec; 19(6):339-50. PubMed ID: 26400814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of DNA Integrity, Applications for Cancer Research.
    Zonta E; Nizard P; Taly V
    Adv Clin Chem; 2015; 70():197-246. PubMed ID: 26231488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Plasma Tumor DNA.
    Parsons HA; Beaver JA; Park BH
    Adv Exp Med Biol; 2016; 882():259-76. PubMed ID: 26987539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
    Kahlert C
    Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
    Ignatiadis M; Lee M; Jeffrey SS
    Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
    Schlange T; Pantel K
    Pharmacogenomics; 2016 Feb; 17(3):183-6. PubMed ID: 26799583
    [No Abstract]   [Full Text] [Related]  

  • 7. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
    Thierry AR
    Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life and death of circulating cell-free DNA.
    Kustanovich A; Schwartz R; Peretz T; Grinshpun A
    Cancer Biol Ther; 2019; 20(8):1057-1067. PubMed ID: 30990132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical role of circulating free tumor DNA in gastrointestinal malignancy.
    Howell JA; Khan SA; Knapp S; Thursz MR; Sharma R
    Transl Res; 2017 May; 183():137-154. PubMed ID: 28056336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
    Cabel L; Proudhon C; Mariani P; Tzanis D; Beinse G; Bieche I; Pierga JY; Bidard FC
    Eur J Surg Oncol; 2017 May; 43(5):949-962. PubMed ID: 28185687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential of Cell-free Circulating DNA in Diagnosis of Cancer].
    Kubaczková V; Sedlaříková L; Bešše L; Almaši M; Hájek R; Ševčíková S
    Klin Onkol; 2015; 28(4):251-9. PubMed ID: 26299738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection.
    Pantel K
    PLoS Med; 2016 Dec; 13(12):e1002205. PubMed ID: 28027295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
    Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
    J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker.
    Christie EL; Dawson SJ; Bowtell DD
    Cancer Res; 2016 Oct; 76(19):5590-5591. PubMed ID: 27698187
    [No Abstract]   [Full Text] [Related]  

  • 15. Liquid Biopsies in Oncology and the Current Regulatory Landscape.
    Strotman LN; Millner LM; Valdes R; Linder MW
    Mol Diagn Ther; 2016 Oct; 20(5):429-36. PubMed ID: 27324559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
    Takai E; Yachida S
    World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Biomarkers for Prediction of Treatment Response.
    Cappelletti V; Appierto V; Tiberio P; Fina E; Callari M; Daidone MG
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):60-3. PubMed ID: 26063889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Biopsy - The Non-invasive Tool for Tracking Cancer.
    Baig S; Jafarey O
    J Coll Physicians Surg Pak; 2018 Jun; 28(6):417-418. PubMed ID: 29848413
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.
    Esposito A; Bardelli A; Criscitiello C; Colombo N; Gelao L; Fumagalli L; Minchella I; Locatelli M; Goldhirsch A; Curigliano G
    Cancer Treat Rev; 2014 Jun; 40(5):648-55. PubMed ID: 24184333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylated circulating tumor DNA in blood: power in cancer prognosis and response.
    Warton K; Mahon KL; Samimi G
    Endocr Relat Cancer; 2016 Mar; 23(3):R157-71. PubMed ID: 26764421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.